- Home
- RERE vs BVS Comparison
RERE vs BVS Comparison
Compare RERE & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RERE | BVS |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | China | United States |
| Employees | N/A | 950 |
| Industry | Other Specialty Stores | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 987.8M | 982.2M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | RERE | BVS |
|---|---|---|
| Price | $4.11 | $14.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 1.1M | 845.8K |
| Earning Date | 05-19-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.27% | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.52 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | $25.70 | $7.52 |
| Revenue Next Year | $22.93 | $7.06 |
| P/E Ratio | $34.57 | ★ $27.65 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.50 | $6.26 |
| 52 Week High | $6.47 | $15.89 |
Technical Indicators
Market Signals| Indicator | RERE | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 44.35 | 58.17 |
| Support Level | $3.96 | $7.29 |
| Resistance Level | $4.29 | $15.89 |
| Average True Range (ATR) | 0.17 | 0.78 |
| MACD | -0.05 | -0.09 |
| Stochastic Oscillator | 13.04 | 44.36 |
Price Performance
Historical ComparisonAbout RERE ATRenew Inc.
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platforms PJT Marketplace and Paipai Marketplace. The Company's principal operations and geographic markets are in the People's Republic of China.
About BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.